Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05244070
Title A Study to Evaluate the Safety and Tolerability of BMS-986403 in Participants With Relapsed and/or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Local Institution - 0005 Birmingham Alabama 35249 United States Details
Local Institution - 0016 Duarte California 91010 United States Details
Local Institution - 0007 Boston Massachusetts 02114 United States Details
Local Institution - 0026 Hackensack New Jersey 07601 United States Details
Local Institution - 0009 Columbus Ohio 43210 United States Details
Local Institution - 0002 Seattle Washington 98109-4433 United States Details
Local Institution - 0024 Barcelona 08035 Spain Details
Local Institution Madrid 28040 Spain Details
Local Institution Salamanca 37007 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field